INTRODUCTION
Pyrazolines, a class of five-membered heterocycles, is recognized for never-ending research and development in terms of therapeutic potential. As a result, pyrazolines have become an obvious core of numerous drugs having diverse activities. 1 The broad spectrum of activities shown by the pyrazolines encourages searchers to modify their structures by building with some biologically important heterocyclic compounds like alkyl, aromatic, heterocyclic rings and other groups at different positions on the ring which helps to create a novel class of desired compounds.
Pyrazoline and its analogs act as significant pharmacies and synthons in the field of organic chemistry and drug designing.
They are well-acknowledged for pharmacologically interesting heterocyclic systems through recent literature survey. 2 Pyrazolines possess a wide range of biological properties such as anticancer, [3] [4] [5] antiinflammatory, 6 antibacterial, 7 anti-depressive and anticonvulsant, 8 antimicrobial, 9 antinociceptives 10 and enzyme inhibitors. 11 Thus pyrazolines are well recognized for various biological activities. 12, 13 Hence, synthesis of new heterocycles bearing pyrazolines remains the core area of research. Numerous methods were developed for the synthesis of pyrazoline and their synthetic counterparts, among which the classical method involves cyclization of the Michael acceptor unit (chalcone) with hydrazine hydrate or phenylhydrazine in the presence of cyclizing agents like acetic acid or simple heating procedure. 14 Thus, considering the biological significance of pyrazolines and in continuation of our efforts in the development of biologically active entities; [15] [16] [17] in the present work, we report the synthesis, characterization, antimicrobial and antioxidant activities of some novel pyrazolines bearing pyridine and benzoisothiazole containing piperazine moiety.
The results of biological activities were supported by molecular docking studies. ADMET study was performed to know the drug-likeness and toxicity profile of the synthesized compounds.
MATERIALS AND METHODS
Melting points were recorded in an electrothermal melting point apparatus and were uncorrected. The consumption of starting material and formation of the products was monitored on silica precoated thin layer chromatography plate using 40 % ethyl acetate : n-hexane as the mobile phase. FTIR spectra were recorded using KBr pellets (100 mg) on Shimadzu FT-IR spectrophotometer. 1 H and 13 C NMR spectra were recorded on Bruker 400 MHz spectrometer and chemical shifts were expressed in δ ppm with reference to tetramethylsilane (TMS) as the internal standard.
In the antimicrobial activity, the zones of inhibition and the antioxidant activity performed spectrophotometrically were expressed as mean ± SD of three replicates.
General procedure for the synthesis of pyrazolines
A mixture of chalcone (0.7g, 0.16 mol) and hydrazine hydrate (1.0 mL) or phenylhydrazine in ethanol (1.0 mL) was stirred for 2 h at 25-35 o C. Sometimes heating at 45-50 o C was required for dehydration. The precipitated solid was filtered off to get a crude product which was crystallized with hot ethanol to get pure white color material. 1 
6-(5-(4-((3,4-Dimethoxypyridin-2-yl)methoxy)-3-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one (6)

2-((4-(4,5-Dihydro-3-phenyl-1H-pyrazol-5-yl)-2-methoxyphenoxy)methyl)-4-methoxy-3,5-dimethylpyridine (7)
2-(5-(4-((4-Methoxy-3,5-dimethyl pyridin-2-yl)methoxy)-3methoxy phenyl) -4,5-dihydro-1H-pyrazol-3-yl)phenol (8)
3-(4-(4-(4-(4,5-Dihydro-3-phenyl-1H-pyrazol-5-yl)-2-methoxyphenoxy)butyl)piperazin-1-yl)benzo[d]isothiazole (12)
3-(4-(4-(4-(3-(4-Fluorophenyl)-4,5-dihydro-1H-pyrazol-5-yl)-2methoxyphenoxy)butyl)piperazin-1-yl) benzo[d]isothiazole (14)
6-((R)-5-(4-(4-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)butoxy)-3-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl)-2Hbenzo[b][1,4]oxazin-3(4H)-one (15)
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3-(4-(4-(4-(4,5-Dihydro-1,3-diphenyl-1H-pyrazol-5-yl)-2-methoxyphenoxy)butyl)piperazin-1-yl)benzo[d]isothiazole (17)
3-(4-(4-(4-(3-(4-Fluorophenyl)-4,5-dihydro-1-phenyl-1H-pyrazol-5-yl)-2-methoxyphenoxy) butyl)piperazin-1-yl)benzo[d]isothiazole (18)
3-(4-(4-(4-(3-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-6-yl)-4,5-dihydro-1-phenyl-1H-pyrazol-5-yl)-2-methoxyphenoxy)butyl)piperazin-1-yl)benzo[d]isothiazole (19)
RESULT AND DISCUSSIONS
In this communication, two new series of pyrazoline containing substituted chloromethyl pyridine and alkoxy linkage side chain containing benzoisothiazole represented as in Schemes 1 and 2. The essentials of synthesized compounds were confirmed by their physical properties and spectroscopic techniques like 1 H NMR, 13 C NMR, Mass spectroscopy and FT-IR.
Substituted chloromethylpyridines were treated with vanillin at room temperature in the presence of potassium carbonate and DMF used as a solvent to get aldehydes. These aldehydes were reacted further with different acetophenones, as shown in Table 1 , in the presence of 30 % aq. KOH solution where ethanol used as a solvent in the reaction to form the respective chalcones. Pyrazolines were synthesized by refluxing chalcones with hydrazine hydrate in the presence of ethanol as the solvent.
Scheme 1. Synthesis of pyrazoline compounds (1-11).
Spectroscopic data confirmed the assigned structure for 1-19, where its 1 H NMR, 13 C NMR and mass spectroscopy where disappearance of the C=C bond two trans proton coupling having J value ~16.0 Hz of chalcones and formation of three peaks displayed in pyrazoline (δ ~2.8, 3.4 and a triplet at ~4.7 ppm (D2O-exchangeable, 1H, NH)). 13 C-NMR shows signals corresponding to respective types of carbon in different chemical shifts of pyrazoline compounds details of the chemical shift were captured in the characterization part. Mass spectroscopy gives corresponding [M+1] molecular ion peak at their corresponding molecular weight, as shown in Table 1 . The IR spectrum of compounds showed a broad band at ~3446 cm -1 recognized for -OH group and the characteristic N=N band was assigned at 1591 cm -1 two strong bands at ~1650 cm -1 and ~1607 cm -1 referring to carbonyl and carbon-carbon double bond disappearance confirmed the formation of pyrazolines compounds.
The synthesized compounds were assigned on the basis of 1 H NMR, 13 C NMR, mass and IR spectral analytical studies to confirm the proposed structures. Physical constant data were tabulated in Table 1 .
Molecular docking
To study binding conformations of the synthesized compounds, the Autodock Vina program was used for docking pyrazoline derivatives into the active sites of methionyl-tRNA synthetase. The AutoDock Tools 1.5.4 (ADT) was used to prepare the input files for docking. 18 The crystal structure of Thermus thermophilus methionyl-tRNA synthetase reveals two RNA-binding modules. All water molecules and ions were removed from the protein crystallographic structures; polar hydrogens were added and partial atomic charges were assigned by Kollman united charges method. [19] [20] [21] Sidechains of lysine, arginine, and histidine residues were protonated while the carboxylic groups of glutamic and aspartic acid were deprotonated. For each ligand, nonpolar hydrogens were merged, Gasteiger charges were assigned and rotatable bonds were set up. The structures were then saved in the corresponding pdbqt file required for the Autodock.
Antioxidant activity
Antioxidant potential of the synthesized compounds was measured in terms of DPPH, OH and superoxide radical (SOR) scavenging activity carried out using reported methods. 22 following the procedure as discussed in our previous publications. 16 The results of antioxidant activity are summarized in Table 2 . The detailed procedure for the antioxidant activity is provided in the supplementary material.
Antimicrobial screening
To confirm the inhibitory activity, the hit compounds were re-tested against the strains in a dose-response assay to determine the minimum inhibitory concentration (MIC) of the compounds. Samples were prepared in DMSO and water to a final testing concentration of 32 μg mL -1 or 20 μM in 384-well, non-binding surface plate (NBS) for each bacterial/fungal strain, in duplicate (n=2), and keeping the final DMSO concentration to a maximum of 1 % DMSO. All the sample-preparation was done using liquid handling robots. All bacteria were cultured in cation-adjusted Mueller Hinton broth (CAMHB) at 37 °C overnight. A sample of each culture was then diluted 40-fold in fresh broth and incubated at 37 °C for 1.5-3 h. The resultant mid-log phase cultures were diluted (CFU mL -1 measured by OD600), added to each well of the compound containing plates giving a cell density of 5×105 CFU mL -1 and a total volume of 50 μL. All the plates were covered and incubated at 37 °C for 18 h without shaking. Fungi strains were cultured for 3 days on yeast extractpeptone dextrose (YPD) agar at 30 °C. A yeast suspension of 1 x 106 to 5 x 106 CFU mL -1 (as determined by OD530) was prepared from five colonies. The suspension was subsequently diluted and added to each well of the compound containing plates giving a final cell density of fungi suspension of 2.5 ×103 CFU mL -1 and a total volume of 50 μL. All plates were covered and incubated at 35 °C for 24 h without shaking.
Colistin and Vancomycin were used as positive bacterial inhibitor standard for gram-negative and gram-positive bacteria, respectively. Fluconazole was used as a positive fungal inhibitor standard for C. Albicans and C. neoformans. The antibiotics were provided in 4 concentrations, with 2 above and 2 below its MIC value, and plated into the first 8 wells of column 23 of the 384-well NBS plates. The quality control (QC) of the assays was determined by the antimicrobial controls and the Z'-factor (using positive and negative controls). Each plate was deemed to fulfill the quality criteria (pass QC) if the Z'-factor was above 0.4, and the antimicrobial standards showed the full range of activity, with full growth inhibition at their highest concentration, and no growth inhibition at their lowest concentration.
The inhibition of bacterial growth was determined by measuring absorbance at 600 nm (OD600) using a Tecan M1000 Pro monochromator plate reader. The percentage of growth inhibition was calculated for each well using the negative control (media only) and positive control (bacteria without inhibitors) on the same plate as references. The significance of the inhibition values was determined by modifying Z-scores, calculated using the median of the samples (no controls) on the same plate. Samples with inhibition values above 80 % and Z-score above 2.5 for either replicate (n=2 on different plates) were classed as actives, whereas samples with inhibition values between 50 -80 % and Z-score below 2.5 for either replicate (n=2 on different plates) were classed as partially active. Percentage growth inhibition of individual samples was calculated based on negative controls (media only) and positive controls (bacterial media without inhibitors). The percentage of growth inhibition was calculated for each well using the negative control (media only) and positive control (without inhibitors) on the same plate. The growth rates for all bacteria and fungi have a variation of -/+ 10 %, which lies is within the expected normal distribution of microbial growth.
Molecular docking
The synthesized compounds were docked against the active site of Thermus thermophilus methionyl-tRNA synthetase using Autodock vina docking tool whose results were expressed in terms of docking scores ( Table 8 ). Analysis of docking interaction reveals that the pyrazoles bearing benzoisothiazole ring (12, 13 and 15) were the most active compounds against methionyl-tRNA synthetase. Results of observed antimicrobial activities are in good agreement for these tilted compounds in terms of higher negative values of Z-scores.
The benzisothiazole linked pyrazolines 12, 13 and 15 bind efficiently into the active site residues like TYR13, GLU54, ARG132, ASP50, ASP260, GLY21, HIS22, LEU290, ILE261, VAL226, and LYS297. The 2H-1,4-benzoxazin-3(4H)-one derivatives 15 (-8.5243) interacts with the polar and charged amino acid residues THR55 and GLU54 with a carbonyl oxygen atom and an oxygen atom of oxazine at the distance of 1.90, 1.93 and 1.93 Å to form conventional hydrogen bond interactions. The charged amino acid ASP50 and hydrophobic amino acid TYR13 form conventional hydrogen bond interactions with pyrazole nitrogen and methoxyl oxygen atom with a distance of 1.87 and 1.90 Å, respectively. The polar amino acid HIS22 and ASP260 amino acid interact with a methoxyl hydrogen atom and the hydrogen atom of the piperazine ring to form a C-H bond and conventional hydrogen bond interactions.
The aliphatic amino acids VAL226, ILE261, GLY288, LEU290, and charged amino acid LYS297 interact with π electron cloud to form π-donor hydrogen and π-alkyl interactions ( Figure 1 ).
The benzoisothiazole derivative 12 (-7.9567) interacts with the polar and charged amino acid of the active site. The charged amino acid ASP260 interacts with hydrogens of the piperazine ring to form conventional hydrogen bond interactions and C-H bond at a distance of 1.96, 2.53, 2.59 and 2.54 Å, respectively. Eur. Chem. Bull., 2020, 9(1), 10-21 http://dx.doi.org/10.17628/ecb.2020.9.6-9
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The polar amino acid THR55 and hydrophobic amino acid TYR13 interacts with pyrazole nitrogen atoms and phenoxy oxygen atom to form conventional hydrogen bond interaction with a distance of 2.00 and 2.52 Å respectively. The π-electron clouds of benzoisothiazole and phenoxy rings create π-sulfur, π-π stacked and π-alkyl interactions with various distances (Figure 2 ).
CONCLUSION
In summary, the present article reports a novel series of pyrazolines from chalcones and hydrazine hydrate or phenylhydrazine in the presence of ethanol as the alcoholic solvent. All structures of the newly synthesized molecules were characterized by spectroscopic data -1 H NMR, 13 C NMR, Mass, and IR. Further, these newly synthesized compounds were evaluated for antioxidant and antimicrobial activity. Compounds 5, 18 and 19 were found to be potentially active antioxidants in terms of the DPPH radical scavenging assay, whereas 2 and 18 compounds showed better activity by superoxide radical (SOR) scavenging assay method in but less as compared with the standard ascorbic acid. Compounds 12, 13 and 15 were partially active against Cryptococcus neoformans var. grubii fungi. The molecular docking study and in-vitro antibacterial and antifungal activity suggested that 12, 13 and 15 are the most active among all synthesized derivatives and will serve as excellent leads in the antimicrobial and antioxidant drug discovery process.
